$CEVA
CEVA INC Stock $ceva

$ceva Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-K Financial Statement

#000143774920003932 Filed on February 28, 2020

Income Statement

Concept	2018 Q4	2017 Q4	2017
Revenue	$21.40M	$21.60M	$87.51M
YoY Change	-0.93%	1.89%	20.45%
Cost Of Revenue	$1.990M	$1.920M	$6.953M
YoY Change	3.65%	17.79%	14.25%
Gross Profit	$19.42M	$19.68M	$80.55M
YoY Change	-1.32%	0.61%	21.01%
Gross Profit Margin	90.75%	91.11%	92.05%
Selling, General & Admin	$5.020M	$6.250M	$23.06M
YoY Change	-19.68%	16.6%	14.69%
% of Gross Profit	25.85%	31.76%	28.63%
Research & Development	$12.00M	$9.970M	$40.39M
YoY Change	20.36%	28.31%	30.96%
% of Gross Profit	61.79%	50.66%	50.13%
Depreciation & Amortization	$1.310M	$870.0K	$2.014M
YoY Change	50.57%	22.54%	43.96%
% of Gross Profit	6.75%	4.42%	2.5%
Operating Expenses	$17.24M	$16.53M	$64.68M
YoY Change	4.3%	22.99%	23.96%
Operating Profit	$2.180M	$3.150M	$15.87M
YoY Change	-30.79%	-48.53%	10.34%
Interest Expense	$880.0K	$880.0K	$3.000M
YoY Change	0.0%	109.52%	50.0%
% of Operating Profit	40.37%	27.94%	18.9%
Other Income/Expense, Net			$0.00
YoY Change
Pretax Income	$2.190M	$4.030M	$18.90M
YoY Change	-45.66%	-38.47%	15.06%
Income Tax	-$120.0K	$860.0K	$1.871M
% Of Pretax Income	-5.48%	21.34%	9.9%
Net Earnings	$2.300M	$3.160M	$17.03M
YoY Change	-27.22%	-39.23%	29.98%
Net Earnings / Revenue	10.75%	14.63%	19.46%
Basic Earnings Per Share			$0.78
Diluted Earnings Per Share	$96.88K	$138.6K	$0.75
COMMON SHARES
Basic Shares Outstanding	21.90M shares	21.97M shares	21.77M
Diluted Shares Outstanding			22.56M

Balance Sheet

Concept	2018 Q4	2017 Q4	2017
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.73M	$104.4M	$138.8M
YoY Change	-4.48%	30.07%	9.72%
Cash & Equivalents	$22.26M	$21.74M	$21.70M
Short-Term Investments	$77.47M	$82.66M	$117.1M
Other Short-Term Assets	$5.300M	$3.700M	$3.700M
YoY Change	43.24%	19.35%	19.35%
Inventory
Prepaid Expenses
Receivables	$26.16M	$16.49M	$16.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$177.3M	$159.1M	$159.1M
YoY Change	11.45%	9.93%	9.95%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.344M	$6.926M	$6.900M
YoY Change	6.04%	44.14%	43.75%
Goodwill	$46.61M	$46.61M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$22.80M	$49.90M	$49.90M
YoY Change	-54.31%	50.3%	50.3%
Other Assets	$5.569M	$3.579M	$12.60M
YoY Change	55.6%	153.47%	23.53%
Total Long-Term Assets	$99.98M	$117.7M	$117.7M
YoY Change	-15.09%	20.41%	20.35%
TOTAL ASSETS
Total Short-Term Assets	$177.3M	$159.1M	$159.1M
Total Long-Term Assets	$99.98M	$117.7M	$117.7M
Total Assets	$277.3M	$276.8M	$276.8M
YoY Change	0.16%	14.15%	14.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$600.0K	$400.0K	$400.0K
YoY Change	50.0%	-33.33%	-33.33%
Accrued Expenses	$4.344M	$3.927M	$16.60M
YoY Change	10.62%	-2.19%	26.72%
Deferred Revenue	$3.593M	$4.399M
YoY Change	-18.32%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$21.75M	$22.80M	$22.80M
YoY Change	-4.58%	0.89%	0.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$9.600M	$9.300M	$9.300M
YoY Change	3.23%	12.05%	12.05%
Total Long-Term Liabilities	$9.632M	$9.300M	$9.300M
YoY Change	3.57%	12.05%	12.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.75M	$22.80M	$22.80M
Total Long-Term Liabilities	$9.632M	$9.300M	$9.300M
Total Liabilities	$31.38M	$32.10M	$32.10M
YoY Change	-2.23%	3.88%	3.88%
SHAREHOLDERS EQUITY
Retained Earnings	$62.85M	$53.87M
YoY Change	16.67%	36.63%
Common Stock	$223.3M	$217.4M
YoY Change	2.68%	2.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$39.13M	$26.06M
YoY Change	50.18%	-34.05%
Treasury Stock Shares	$1.807M	$1.531M
Shareholders Equity	$245.9M	$244.7M	$244.7M
YoY Change
Total Liabilities & Shareholders Equity	$277.3M	$276.8M	$276.8M
YoY Change	0.16%	14.15%	14.14%

Cashflow Statement

Concept	2018 Q4	2017 Q4	2017
OPERATING ACTIVITIES
Net Income	$2.300M	$3.160M	$17.03M
YoY Change	-27.22%	-39.23%	29.98%
Depreciation, Depletion And Amortization	$1.310M	$870.0K	$2.014M
YoY Change	50.57%	22.54%	43.96%
Cash From Operating Activities	$4.530M	$6.770M	$24.47M
YoY Change	-33.09%	-45.8%	69.23%
INVESTING ACTIVITIES
Capital Expenditures	-$410.0K	-$800.0K	$4.135M
YoY Change	-48.75%	122.22%	73.23%
Acquisitions
YoY Change
Other Investing Activities	$12.23M	-$7.770M	-$24.65M
YoY Change	-257.4%	-45.36%	32.24%
Cash From Investing Activities	$11.83M	-$8.570M	-$28.79M
YoY Change	-238.04%	-41.22%	36.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.270M	590.0K	7.487M
YoY Change	-654.24%	-4.84%	20.8%
NET CHANGE
Cash From Operating Activities	4.530M	6.770M	24.47M
Cash From Investing Activities	11.83M	-8.570M	-28.79M
Cash From Financing Activities	-3.270M	590.0K	7.487M
Net Change In Cash	13.09M	-1.210M	3.170M
YoY Change	-1181.82%	-17.69%	-949.87%
FREE CASH FLOW
Cash From Operating Activities	$4.530M	$6.770M	$24.47M
Capital Expenditures	-$410.0K	-$800.0K	$4.135M
Free Cash Flow	$4.940M	$7.570M	$20.33M
YoY Change	-34.74%	-41.09%	68.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2017	ceva	Effective Income Tax Rate Reconciliation Impacts Of Gilti EffectiveIncomeTaxRateReconciliationImpactsOfGILTI
CY2018	ceva	Effective Income Tax Rate Reconciliation Impacts Of Gilti EffectiveIncomeTaxRateReconciliationImpactsOfGILTI	880000
CY2019	ceva	Effective Income Tax Rate Reconciliation Impacts Of Gilti EffectiveIncomeTaxRateReconciliationImpactsOfGILTI	967000
CY2018Q4	ceva	Accrued Engineering Costs Current AccruedEngineeringCostsCurrent	884000
CY2019Q4	ceva	Accrued Engineering Costs Current AccruedEngineeringCostsCurrent	788000
CY2018Q4	ceva	Accrued Expenses Intangible Assets AccruedExpensesIntangibleAssets	750000
CY2019Q4	ceva	Accrued Expenses Intangible Assets AccruedExpensesIntangibleAssets	204000
CY2018Q4	ceva	Accrued Severance Pay Noncurrent AccruedSeverancePayNoncurrent	9632000
CY2019Q4	ceva	Accrued Severance Pay Noncurrent AccruedSeverancePayNoncurrent	10551000
CY2019Q4	ceva	Accumulated Other Comprehensive Income Loss Availableforsale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeLossAvailableforsaleSecuritiesAdjustmentTax	-5000
CY2019Q4	ceva	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesTax	-7000
CY2018	ceva	Amortization Of Intangible Assets Including Portion In Cost Of Revenues AmortizationOfIntangibleAssetsIncludingPortionInCostOfRevenues	1242000
CY2019	ceva	Amortization Of Intangible Assets Including Portion In Cost Of Revenues AmortizationOfIntangibleAssetsIncludingPortionInCostOfRevenues	2165000
CY2019Q4	ceva	Available For Sale Matures After One Year Through Five Years Gross Unrealized Gains AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains	168000
CY2018Q4	ceva	Available For Sale Matures After One Year Through Five Years Gross Unrealized Gains AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedGains	134000
CY2019Q4	ceva	Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss	123000
CY2018Q4	ceva	Available For Sale Matures After One Year Through Five Years Gross Unrealized Loss AvailableForSaleMaturesAfterOneYearThroughFiveYearsGrossUnrealizedLoss	1325000
CY2019Q4	ceva	Available For Sale Matures Within One Year Gross Unrealized Gains AvailableForSaleMaturesWithinOneYearGrossUnrealizedGains	16000
CY2018Q4	ceva	Available For Sale Matures Within One Year Gross Unrealized Gains AvailableForSaleMaturesWithinOneYearGrossUnrealizedGains
CY2019Q4	ceva	Available For Sale Matures Within One Year Gross Unrealized Loss AvailableForSaleMaturesWithinOneYearGrossUnrealizedLoss	11000
CY2018Q4	ceva	Available For Sale Matures Within One Year Gross Unrealized Loss AvailableForSaleMaturesWithinOneYearGrossUnrealizedLoss	32000
CY2017	ceva	Changes In Operating Assets And Liabilities Operating Lease Liability ChangesInOperatingAssetsAndLiabilitiesOperatingLeaseLiability
CY2018	ceva	Changes In Operating Assets And Liabilities Operating Lease Liability ChangesInOperatingAssetsAndLiabilitiesOperatingLeaseLiability
CY2019	ceva	Changes In Operating Assets And Liabilities Operating Lease Liability ChangesInOperatingAssetsAndLiabilitiesOperatingLeaseLiability	-1166000
CY2017	ceva	Changes In Operating Assets And Liabilities Operating Lease Right Of Use Assets ChangesInOperatingAssetsAndLiabilitiesOperatingLeaseRightOfUseAssets
CY2018	ceva	Changes In Operating Assets And Liabilities Operating Lease Right Of Use Assets ChangesInOperatingAssetsAndLiabilitiesOperatingLeaseRightOfUseAssets
CY2019	ceva	Changes In Operating Assets And Liabilities Operating Lease Right Of Use Assets ChangesInOperatingAssetsAndLiabilitiesOperatingLeaseRightOfUseAssets	-1281000
CY2019	ceva	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1
CY2018Q4	ceva	Deferred Tax Assets Right Of Use Asset DeferredTaxAssetsRightOfUseAsset
CY2019Q4	ceva	Deferred Tax Assets Right Of Use Asset DeferredTaxAssetsRightOfUseAsset	1546000
CY2018Q4	ceva	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities And Deferred Revenues DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesAndDeferredRevenues	1274000
CY2019Q4	ceva	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities And Deferred Revenues DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesAndDeferredRevenues	1455000
CY2019	ceva	Defined Contribution Plan Contribution Rate DefinedContributionPlanContributionRate	0.1
CY2017	ceva	Earnings Per Share Basic And Diluted Effect Of Foreign Income Tax Adjustment Reduced Exempt EarningsPerShareBasicAndDilutedEffectOfForeignIncomeTaxAdjustmentReducedExempt	0.12
CY2018	ceva	Earnings Per Share Basic And Diluted Effect Of Foreign Income Tax Adjustment Reduced Exempt EarningsPerShareBasicAndDilutedEffectOfForeignIncomeTaxAdjustmentReducedExempt	0.01
CY2019	ceva	Earnings Per Share Basic And Diluted Effect Of Foreign Income Tax Adjustment Reduced Exempt EarningsPerShareBasicAndDilutedEffectOfForeignIncomeTaxAdjustmentReducedExempt	0.01
CY2018Q4	ceva	Grant Payable GrantPayable	417000
CY2019Q4	ceva	Grant Payable GrantPayable	527000
CY2018	ceva	Impact Of Adoption Of Accounting Standards Update ImpactOfAdoptionOfAccountingStandardsUpdate	8555000
CY2017	ceva	Income Tax Reconciliation Changes In Uncertain Tax Positions IncomeTaxReconciliationChangesInUncertainTaxPositions	-1757000
CY2018	ceva	Income Tax Reconciliation Changes In Uncertain Tax Positions IncomeTaxReconciliationChangesInUncertainTaxPositions	16000
CY2019	ceva	Income Tax Reconciliation Changes In Uncertain Tax Positions IncomeTaxReconciliationChangesInUncertainTaxPositions	-1029000
CY2017	ceva	Income Tax Reconciliation Non Taxable Items IncomeTaxReconciliationNonTaxableItems	529000
CY2018	ceva	Income Tax Reconciliation Non Taxable Items IncomeTaxReconciliationNonTaxableItems	434000
CY2019	ceva	Income Tax Reconciliation Non Taxable Items IncomeTaxReconciliationNonTaxableItems	486000
CY2017	ceva	Income Tax Reconciliation Reduced Exempt IncomeTaxReconciliationReducedExempt	2698000
CY2018	ceva	Income Tax Reconciliation Reduced Exempt IncomeTaxReconciliationReducedExempt	239000
CY2019	ceva	Income Tax Reconciliation Reduced Exempt IncomeTaxReconciliationReducedExempt	154000
CY2017	ceva	Income Tax Reconciliation Subpart F Income IncomeTaxReconciliationSubpartFIncome	737000
CY2018	ceva	Income Tax Reconciliation Subpart F Income IncomeTaxReconciliationSubpartFIncome	563000
CY2019	ceva	Income Tax Reconciliation Subpart F Income IncomeTaxReconciliationSubpartFIncome	568000
CY2017	ceva	Increase Decrease In Accounts Receivable And Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndUnbilledReceivables	1446000
CY2018	ceva	Increase Decrease In Accounts Receivable And Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndUnbilledReceivables	463000
CY2019	ceva	Increase Decrease In Accounts Receivable And Unbilled Receivables IncreaseDecreaseInAccountsReceivableAndUnbilledReceivables	2151000
CY2017	ceva	Increase Decrease In Accrued Interest On Bank Deposits IncreaseDecreaseInAccruedInterestOnBankDeposits	-151000
CY2018	ceva	Increase Decrease In Accrued Interest On Bank Deposits IncreaseDecreaseInAccruedInterestOnBankDeposits	557000
CY2019	ceva	Increase Decrease In Accrued Interest On Bank Deposits IncreaseDecreaseInAccruedInterestOnBankDeposits	161000
CY2017	ceva	Increase Decrease In Accrued Salaries And Related Expenses IncreaseDecreaseInAccruedSalariesAndRelatedExpenses	-1807000
CY2018	ceva	Increase Decrease In Accrued Salaries And Related Expenses IncreaseDecreaseInAccruedSalariesAndRelatedExpenses	527000
CY2019	ceva	Increase Decrease In Accrued Salaries And Related Expenses IncreaseDecreaseInAccruedSalariesAndRelatedExpenses	-3056000
CY2017	ceva	Increase Decrease In Accrued Severance Pay Net IncreaseDecreaseInAccruedSeverancePayNet	-21000
CY2018	ceva	Increase Decrease In Accrued Severance Pay Net IncreaseDecreaseInAccruedSeverancePayNet	215000
CY2019	ceva	Increase Decrease In Accrued Severance Pay Net IncreaseDecreaseInAccruedSeverancePayNet	9000
CY2017	ceva	Increase Decrease In Deferred Tax Net IncreaseDecreaseInDeferredTaxNet	-1375000
CY2018	ceva	Increase Decrease In Deferred Tax Net IncreaseDecreaseInDeferredTaxNet	-2187000
CY2019	ceva	Increase Decrease In Deferred Tax Net IncreaseDecreaseInDeferredTaxNet	-3594000
CY2017	ceva	Intangible Assets Expenditures Incurred But Not Yet Paid IntangibleAssetsExpendituresIncurredButNotYetPaid
CY2018	ceva	Intangible Assets Expenditures Incurred But Not Yet Paid IntangibleAssetsExpendituresIncurredButNotYetPaid	750000
CY2019	ceva	Intangible Assets Expenditures Incurred But Not Yet Paid IntangibleAssetsExpendituresIncurredButNotYetPaid
CY2017	ceva	Investment In Bank Deposits InvestmentInBankDeposits	47027000
CY2018	ceva	Investment In Bank Deposits InvestmentInBankDeposits	21596000
CY2019	ceva	Investment In Bank Deposits InvestmentInBankDeposits	39346000
CY2018Q4	ceva	Longterm Bank Deposits LongtermBankDeposits	21864000
CY2019Q4	ceva	Longterm Bank Deposits LongtermBankDeposits	5368000
CY2017	ceva	Proceeds From Bank Deposits ProceedsFromBankDeposits	44450000
CY2018	ceva	Proceeds From Bank Deposits ProceedsFromBankDeposits	32892000
CY2019	ceva	Proceeds From Bank Deposits ProceedsFromBankDeposits	45435000
CY2017	ceva	Reduction From Research And Development Expenses Due To Receipt Of Grants ReductionFromResearchAndDevelopmentExpensesDueToReceiptOfGrants	4137000
CY2018	ceva	Reduction From Research And Development Expenses Due To Receipt Of Grants ReductionFromResearchAndDevelopmentExpensesDueToReceiptOfGrants	3352000
CY2019	ceva	Reduction From Research And Development Expenses Due To Receipt Of Grants ReductionFromResearchAndDevelopmentExpensesDueToReceiptOfGrants	5643000
CY2017	ceva	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	1555000
CY2018	ceva	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	2065000
CY2019	ceva	Research And Development Tax Credit ResearchAndDevelopmentTaxCredit	2312000
CY2019	ceva	Sales Commission Expected Amortization Period Within Which The Sales Commission Fee Is Expensed When Incurred SalesCommissionExpectedAmortizationPeriodWithinWhichTheSalesCommissionFeeIsExpensedWhenIncurred	P1Y
CY2018Q4	ceva	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	9026000
CY2019Q4	ceva	Severance Pay Fund Noncurrent SeverancePayFundNoncurrent	9881000
CY2017	ceva	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeiture	0
CY2018	ceva	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeiture	0
CY2019	ceva	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeiture	0
CY2019Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageExercisePrice	19.80
CY2019	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisableWeightedAverageRemainingContractualTerm	P3Y146D
CY2017	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodIntrinsicValue	15188000
CY2018	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodIntrinsicValue	384000
CY2019	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Exercises In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsExercisesInPeriodIntrinsicValue	629000
CY2017	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod	0
CY2018	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod	0
CY2019	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsGrantsInPeriod	0
CY2018Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber	702817
CY2019Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingNumber	642253
CY2019Q4	ceva	Share Based Compensation Arrangement By Share Based Payment Award Options And Stock Appreciation Rights Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndStockAppreciationRightsWeightedAverageExercisePrice	20.14
CY2010Q4	ceva	Share Repurchase Program Additional Number Of Shares Authorized To Be Repurchased ShareRepurchaseProgramAdditionalNumberOfSharesAuthorizedToBeRepurchased	5000000
CY2013Q4	ceva	Share Repurchase Program Additional Number Of Shares Authorized To Be Repurchased ShareRepurchaseProgramAdditionalNumberOfSharesAuthorizedToBeRepurchased	5000000
CY2014Q4	ceva	Share Repurchase Program Additional Number Of Shares Authorized To Be Repurchased ShareRepurchaseProgramAdditionalNumberOfSharesAuthorizedToBeRepurchased	5000000
CY2019Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueExercisable	4718000
CY2018Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueOutstanding	2708000
CY2019Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsAggregateIntrinsicValueOutstanding	4718000
CY2019	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Execisable Weighted Average Remaining Contractual Terms SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExecisableWeightedAverageRemainingContractualTerms	P3Y146D
CY2019Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercisable Number SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisableNumber	616253
CY2019	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercised In Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisedInPeriod	54834
CY2019	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Exercised Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsExercisedWeightedaverageExercisePrice	16.71
CY2019	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Forfeited Or Expired In Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsForfeitedOrExpiredInPeriod	5730
CY2019	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Forfeited Or Expired Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsForfeitedOrExpiredWeightedaverageExercisePrice	20.08
CY2018	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm	P4Y109D
CY2019	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedAverageRemainingContractualTerm	P3Y182D
CY2018Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedaverageExercisePrice	19.88
CY2019Q4	ceva	Sharebased Compensation Arrangement By Sharebased Payment Award Options And Stock Appreciation Rights Outstanding Weightedaverage Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndStockAppreciationRightsOutstandingWeightedaverageExercisePrice	20.14
CY2018Q4	ceva	Shortterm Bank Deposits ShorttermBankDeposits	46139000
CY2019Q4	ceva	Shortterm Bank Deposits ShorttermBankDeposits	56915000
CY2017	ceva	Tax Cuts And Jobs Act Of2017 Repatriation Foreign Earnings Income Tax Expense Benefit TaxCutsAndJobsActOf2017RepatriationForeignEarningsIncomeTaxExpenseBenefit	1916000
CY2018	ceva	Tax Cuts And Jobs Act Of2017 Repatriation Foreign Earnings Income Tax Expense Benefit TaxCutsAndJobsActOf2017RepatriationForeignEarningsIncomeTaxExpenseBenefit	3542000
CY2019	ceva	Tax Cuts And Jobs Act Of2017 Repatriation Foreign Earnings Income Tax Expense Benefit TaxCutsAndJobsActOf2017RepatriationForeignEarningsIncomeTaxExpenseBenefit
CY2017	ceva	Tax Cuts And Jobs Act Of2017 Transition Tax Income Tax Expense Benefit TaxCutsAndJobsActOf2017TransitionTaxIncomeTaxExpenseBenefit	16053000
CY2019	ceva	Technical Support Period TechnicalSupportPeriod	P1Y
CY2017	ceva	Treasury Stock Issued During Period Value Stock Options Exercised TreasuryStockIssuedDuringPeriodValueStockOptionsExercised	7487000
CY2018	ceva	Treasury Stock Issued During Period Value Stock Options Exercised TreasuryStockIssuedDuringPeriodValueStockOptionsExercised	2249000
CY2019	ceva	Treasury Stock Issued During Period Value Stock Options Exercised TreasuryStockIssuedDuringPeriodValueStockOptionsExercised	2437000
CY2018	ceva	Treasury Stock Value Acquired Weighted Average Method TreasuryStockValueAcquiredWeightedAverageMethod	20008000
CY2019	ceva	Treasury Stock Value Acquired Weighted Average Method TreasuryStockValueAcquiredWeightedAverageMethod	9113000
CY2019Q2	dei	Entity Public Float EntityPublicFloat	389722000
CY2019	dei	Entity Registrant Name EntityRegistrantName	CEVA INC
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Security12b Title Security12bTitle	Common Stock, $.001 per share
CY2019	dei	Trading Symbol TradingSymbol	ceva
CY2019	ceva	Unrecognized Tax Benefits Decreases Resulting From Tax Audit Completion UnrecognizedTaxBenefitsDecreasesResultingFromTaxAuditCompletion	2164000
CY2018	ceva	Unrecognized Tax Benefits Decreases Resulting From Tax Audit Completion UnrecognizedTaxBenefitsDecreasesResultingFromTaxAuditCompletion
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001173489
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22192153
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	632000
CY2019Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	701000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26156000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	28307000
CY2018Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	141000
CY2019Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	88000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4344000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3748000
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	752000
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	629000
CY2018Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	259000
CY2019Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	284000
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12799000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15560000
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1114000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	94000
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	223250000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	228005000
CY2017	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1236000
CY2018	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1242000
CY2019	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2165000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8693000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10367000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10718000
CY2017	us-gaap	Advertising Expense AdvertisingExpense	1118000
CY2018	us-gaap	Advertising Expense AdvertisingExpense	1080000
CY2019	us-gaap	Advertising Expense AdvertisingExpense	996000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8693000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10367000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10718000
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	327000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs
CY2018	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs
CY2017	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1236000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	901000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1923000
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	29892
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	161362
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	184947
CY2018Q4	us-gaap	Assets Assets	277263000
CY2019Q4	us-gaap	Assets Assets	297021000
CY2018Q4	us-gaap	Assets Current AssetsCurrent	177288000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	178552000
CY2018Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	99975000
CY2019Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	118469000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	184000
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	134000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	134000
CY2018Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1357000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	64817000
CY2018Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	78692000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22260000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22803000
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3338000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	22852000
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	16580000
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	521000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	102000
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	192000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	32000
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	543000
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1165000
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	22000
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	14000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	21000
CY2019Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	96000
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18401000
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21739000
CY2019Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	14231000
CY2018Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	52590000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	46593000
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	72598000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	46638000
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	71407000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	18224000
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	6094000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	18229000
CY2018Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	6062000
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	77469000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	64867000
CY2017	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet
CY2018	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-67000
CY2019	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	-28000
CY2017	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	47000
CY2018	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	4000
CY2019	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	13000
CY2017	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	47000
CY2018	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	71000
CY2019	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	41000
CY2019Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	10000000
CY2019Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	2937000
CY2019Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	7063000
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23595160
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23595160
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21787860
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	16939000
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	46000
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21839369
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	24466000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1236000
CY2018Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3194000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	22000
CY2019Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3123000
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6038000
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration of credit risk</div></div><div style="display: inline; font-style: italic;">: </div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, bank deposits, marketable securities, foreign exchange contracts and trade receivables. The Company invests its surplus cash in cash deposits and marketable securities in financial institutions and has established guidelines relating to diversification and maturities to maintain safety and liquidity of the investments.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The majority of the Company’s cash and cash equivalents are invested in high grade certificates of deposits with major U.S., European and Israeli banks. Generally, cash and cash equivalents and bank deposits <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be redeemed on demand and therefore minimal credit risk exists with respect to them.   Nonetheless, deposits with these banks exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits or similar limits in foreign jurisdictions, to the extent such deposits are even insured in such foreign jurisdictions. Generally, these cash equivalents <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be redeemed upon demand and, therefore management believes that it bears a lower risk. The short-term and long-term bank deposits are held in financial institutions which management believes are institutions with high credit standing, and accordingly, minimal credit risk from geographic or credit concentration. Furthermore, the Company holds an investment portfolio consisting principally of corporate bonds. The Company has the ability to hold such investments until recovery of temporary declines in market value or maturity; accordingly, as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> the Company believes the losses associated with its investments are temporary and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> impairment loss was recognized during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> However, the Company can provide <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurance that it will recover declines in the market value of its investments.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The Company is exposed primarily to fluctuations in the level of U.S. interest rates. To the extent that interest rates rise, fixed interest investments <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be adversely impacted, whereas a decline in interest rates <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>decrease the anticipated interest income for variable rate investments.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The Company is exposed to financial market risks, including changes in interest rates. The Company typically does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> attempt to reduce or eliminate its market exposures on its investment securities because the majority of its investments are short-term.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The Company’s trade receivables are geographically diverse, mainly in the Asia Pacific, and also in the United States and Europe. Concentration of credit risk with respect to trade receivables is limited by credit limits, ongoing credit evaluation and account monitoring procedures. The Company performs ongoing credit evaluations of its customers and to date has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any material losses. The Company makes judgments on its ability to collect outstanding receivables and provides allowances for the portion of receivables for which collection becomes doubtful. Provisions are made based upon a specific review of all significant outstanding receivables. In determining the provision, the Company considers the expected collectability of receivables.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"> </div> <div> <table style="margin-right: 10%; margin-left: 54pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Balance at</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">beginning of period</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Additions</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Deduction</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Balance at</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">end of period</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Year ended December 31, 2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">327</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">327</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Year ended December 31, 2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Year ended December 31, 2017</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 36pt;">The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> off-balance-sheet concentration of credit risk.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3593000
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3642000
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3593000
CY2019Q4	us-gaap	Contractual Obligation ContractualObligation	12206000
CY2019Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	123000
CY2019Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	5638000
CY2019Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	4312000
CY2019Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	2133000
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	6953000
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	7951000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	10106000
CY2017	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1
CY2018	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	8555000
CY2019	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-227000
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3000
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3473000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2913000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1936000
CY2017	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss
CY2018	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-67000
CY2019	us-gaap	Debt Securities Available For Sale Unrealized Gain Loss DebtSecuritiesAvailableForSaleUnrealizedGainLoss	-28000
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1375000
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2187000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-600000
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5924000
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	10605000
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	114000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1546000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	18783000
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	5924000
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	10605000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	12151000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9505000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8778000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7826000
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	705000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	502000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1381000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	5666000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2724000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	3396000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12745000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12315000
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	114000
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
CY2018Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1546000
CY2017	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	988000
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1048000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1189000
CY2019	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2019	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1
CY2019	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.15
CY2018	us-gaap	Depreciation Depreciation	2915000
CY2019	us-gaap	Depreciation Depreciation	3104000
CY2017	us-gaap	Depreciation Depreciation	2014000
CY2017	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	189000
CY2018	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-354000
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	307000
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	168000
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-159000
CY2019	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-12000
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13183000
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	15894000
CY2019Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1806000
CY2019Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	936000
CY2019Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Downward Price Adjustment Cumulative Amount EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount	870000
CY2017	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5661000
CY2019	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2018	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1852000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1906000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2581000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2582000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1915000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2588000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8361000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	21250000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13424000
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2700000
CY2019Q4	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	56000
CY2018Q4	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure
CY2018Q4	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	77000
CY2019Q4	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-28000
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-241000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-347000
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	42000
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-155000
CY2019	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-249000
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10488000
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10354000
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11841000
CY2017Q4	us-gaap	Goodwill Goodwill	46612000
CY2018Q4	us-gaap	Goodwill Goodwill	46612000
CY2019Q4	us-gaap	Goodwill Goodwill	51070000
CY2018	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4458000
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2017	us-gaap	Gross Profit GrossProfit	80554000
CY2018	us-gaap	Gross Profit GrossProfit	69926000
CY2019	us-gaap	Gross Profit GrossProfit	77046000
CY2019	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2018	us-gaap	Impairment Of Investments ImpairmentOfInvestments	870000
CY2017	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	96000
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-53000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5680000
CY2017	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2019	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2018	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-5946000
CY2017	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1859000
CY2018	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-806000
CY2018	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	226000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9039000
CY2019	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	53000
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1493000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18899000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1303000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1367000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	24845000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	6983000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	10406000
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18899000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1303000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1367000
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1871000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	729000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1339000
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2076000
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-5005000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-209000
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-2304000
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	369000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-33000
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	6426000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	274000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	287000
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	294000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	217000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	124000
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1503000
CY2018	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-62000
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-3000
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-787000
CY2018	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	608000
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1307000
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5203000
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4294000
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5063000
CY2017	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-184000
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	85000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3855000
CY2017	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1259000
CY2018	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-493000
CY2019	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-131000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2478000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4170000
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	790000
CY2018	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	469000
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	391000
CY2017	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	1179000
CY2018	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	773000
CY2019	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	554000
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	4233000
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	4499000
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	4220000
CY2017	us-gaap	Investment Income Net InvestmentIncomeNet	3026000
CY2018	us-gaap	Investment Income Net InvestmentIncomeNet	3418000
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	3291000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	12298000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4228000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2434000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1089000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1271000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1481000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1795000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1632000
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	277263000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	297021000
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21752000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26378000
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9632000
CY2019Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	19486000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7487000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17759000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6676000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28786000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9827000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2443000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24469000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8612000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9674000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	17028000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	574000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	28000
CY2018Q4	us-gaap	Noncurrent Assets NoncurrentAssets	7344000
CY2019Q4	us-gaap	Noncurrent Assets NoncurrentAssets	18945000
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2017	us-gaap	Operating Expenses OperatingExpenses	64681000
CY2018	us-gaap	Operating Expenses OperatingExpenses	71171000
CY2019	us-gaap	Operating Expenses OperatingExpenses	78970000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	15873000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-1245000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-1924000
CY2018	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	19666000
CY2019	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	27184000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11066000
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0373
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y237D
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	2238000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	10666000
CY2017	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2393000
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8273000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	2173000
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2018Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent
CY2019Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	662000
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5569000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8240000
CY2017	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-99000
CY2018	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-545000
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	1273000
CY2017	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-105000
CY2018	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-622000
CY2019	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	1406000
CY2017	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax	-6000
CY2018	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax	-77000
CY2019	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Before Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesBeforeTax	133000
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-89000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-528000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1208000
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
CY2018	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-67000
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-28000
CY2017	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax	189000
CY2018	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax	-354000
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax	307000
CY2017	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-16000
CY2018	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-94000
CY2019	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	198000
CY2017	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	183000
CY2018	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-431000
CY2019	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	440000
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-99000
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-612000
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1245000
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1141000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1228000
CY2018Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	936000
CY2019Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	936000
CY2017	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	0
CY2019	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	0
CY2018	us-gaap	Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings	0
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	20008000
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9113000
CY2017	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	54882000
CY2018	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	11000000
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1960000
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7364000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4135000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3319000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3461000
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5264000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5660000
CY2017	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7487000
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2249000
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2437000
CY2017	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	9296000
CY2018	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10122000
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3888000
CY2017	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	23512000
CY2018	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	13354000
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	36589000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20143000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23439000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7344000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7879000
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.011
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.022
CY2008Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	1000000
CY2019Q4	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	0
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	327000
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	40385000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	47755000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52843000
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	62853000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	62426000
CY2017	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	87507000
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	77877000
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	87152000
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	16269000
CY2019Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1889000
CY2017	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2493000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.43
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.28
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.35
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.42
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.025
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.02
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.005
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.007
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
CY2018	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	655876
CY2017	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12572000
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12161000
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12363000
CY2017	us-gaap	Severance Costs1 SeveranceCosts1	1413000
CY2018	us-gaap	Severance Costs1 SeveranceCosts1	1818000
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	1826000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	8693000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	10367000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	10718000
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.46
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.42
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	211551000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	244670000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	245879000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	251157000
CY2018	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	30.51
CY2019	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	25.66
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1807300
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1755791
CY2017	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	355180
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	39132000
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	39390000
CY2018	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	20008000
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9113000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2739000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1037000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2224000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	60000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	16000
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	575000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	478000
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of estimates</div></div><div style="display: inline; font-style: italic;">:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22561000
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22503000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22323000
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21771000
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22034000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21932000

Files In Submission

Name	View Source	Status
0001437749-20-003932-index-headers.html	Edgar Link	pending
0001437749-20-003932-index.html	Edgar Link	pending
0001437749-20-003932.txt	Edgar Link	pending
0001437749-20-003932-xbrl.zip	Edgar Link	pending
a1.jpg	Edgar Link	pending
a2.jpg	Edgar Link	pending
a3.jpg	Edgar Link	pending
ceva-20191231.xml	Edgar Link	completed
ceva-20191231.xsd	Edgar Link	pending
ceva-20191231_cal.xml	Edgar Link	unprocessable
ceva-20191231_def.xml	Edgar Link	unprocessable
ceva-20191231_lab.xml	Edgar Link	unprocessable
ceva-20191231_pre.xml	Edgar Link	unprocessable
ceva20191231_10k.htm	Edgar Link	pending
ex_174273.htm	Edgar Link	pending
ex_174274.htm	Edgar Link	pending
ex_174275.htm	Edgar Link	pending
ex_174276.htm	Edgar Link	pending
ex_174277.htm	Edgar Link	pending
ex_174503.htm	Edgar Link	pending
ex_174548.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
graph01.jpg	Edgar Link	pending
logo.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CEVA
CEVA INC Stock $ceva

2018 Q4 Form 10-K Financial Statement

#000143774920003932 Filed on February 28, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEVA CEVA INC Stock $ceva

2018 Q4 Form 10-K Financial Statement

#000143774920003932 Filed on February 28, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CEVA
CEVA INC Stock $ceva